Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXP0NZ
|
||||
| Drug Name |
3-(4-Hydroxy-3-methoxy-phenyl)-2-pyridin-2-yl-acrylonitrile
|
||||
| Synonyms |
CHEMBL39295
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C15H12N2O2
|
||||
| Canonical SMILES |
COc1cc(\\C=C(/C#N)\\c2ccccn2)ccc1O
|
||||
| InChI |
InChI=1S/C15H12N2O2/c1-19-15-9-11(5-6-14(15)18)8-12(10-16)13-4-2-3-7-17-13/h2-9,18H,1H3/b12-8+
|
||||
| InChIKey |
VNGWLLJZPDZEQS-XYOKQWHBSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Epidermal growth factor receptor III | Target Info | [1587926] | ||
| Insulin-like growth factor I receptor | Target Info | [1587926] | |||
| KEGG Pathway | Ras signaling pathway | ||||
| Rap1 signaling pathway | |||||
| HIF-1 signaling pathway | |||||
| FoxO signaling pathway | |||||
| Oocyte meiosis | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| AMPK signaling pathway | |||||
| Focal adhesion | |||||
| Adherens junction | |||||
| Signaling pathways regulating pluripotency of stem cells | |||||
| Long-term depression | |||||
| Ovarian steroidogenesis | |||||
| Progesterone-mediated oocyte maturation | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Proteoglycans in cancer | |||||
| Glioma | |||||
| Prostate cancer | |||||
| Melanoma | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.